ACT-EARLY
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
Eidos Therapeutics
Start Date
September 21, 2021
End Date
February 9, 2022
Administered By
Duke Clinical Research Institute
Awarded By
Eidos Therapeutics
Start Date
September 21, 2021
End Date
February 9, 2022